Skip to main content
Journal of Nuclear Medicine logoLink to Journal of Nuclear Medicine
. 2022 Jul;63(7):100–1000.

Errata

PMCID: PMC11927088  PMID: 35772958

In the article “18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies,” by Minoshima et al. (J Nucl Med. 2022; 63:2S–12S), Figures 4 and 5 were switched. Figure 4 should be Figure 5 and Figure 5 should be Figure 4; the legends are correct. We regret the error.

In the article “Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study,” by Shi et al. (J Nucl Med. 2020;61:1814–1819), the author line neglected to mention that Zhihong Shi, Li-ping Fu, Nan Zhang, and Xiaobin Zhao also contributed equally to this work. The authors regret the error.

In the article “Production and Supply of α-Particle -Emitting Radionuclides for Targeted α-Therapy,” by Radchenko et al. (J Nucl Med. 2021;62: 1495–1503), affiliation 10 is incorrect. Bayer American Samoa should be Bayer AS. We regret the error.

In the article “177Lu-Prostate-Specific Membrane Antigen Ligand After 223Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience,” by Sartor et al. (J Nucl Med. 2022;63:410–414), affiliation 9 is incorrect. The correct affiliation should be Nuclear Medicine and Radiometabolic Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy. The authors regret the error.


Articles from Journal of Nuclear Medicine are provided here courtesy of Society of Nuclear Medicine and Molecular Imaging

RESOURCES